22063
A once - daily subcutaneous formulation of lixisenatide has been approved in the EU , Iceland , Liechtenstein , Norway and Mexico for the treatment of type 2 diabetes , and is under regulatory review in the USA , Switzerland , Brazil , Canada , Ukraine , South Africa , Japan and Australia .
 None
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 None